Nang Kuang Pharmaceutical Co., Ltd. (TPE:1752)
36.40
-0.05 (-0.14%)
Jan 22, 2026, 1:35 PM CST
Nang Kuang Pharmaceutical Revenue
Nang Kuang Pharmaceutical had revenue of 523.84M TWD in the quarter ending September 30, 2025, a decrease of -9.67%. This brings the company's revenue in the last twelve months to 2.22B, up 4.08% year-over-year. In the year 2024, Nang Kuang Pharmaceutical had annual revenue of 2.20B with 2.31% growth.
Revenue (ttm)
2.22B
Revenue Growth
+4.08%
P/S Ratio
1.66
Revenue / Employee
4.03M
Employees
552
Market Cap
3.69B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.20B | 49.63M | 2.31% |
| Dec 31, 2023 | 2.15B | 209.74M | 10.81% |
| Dec 31, 2022 | 1.94B | 160.39M | 9.01% |
| Dec 31, 2021 | 1.78B | 25.27M | 1.44% |
| Dec 31, 2020 | 1.75B | -7.43M | -0.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BenQ Medical Technology | 5.20B |
| St.Shine Optical | 4.40B |
| Formosa Optical Technology | 3.98B |
| Pacific Hospital Supply | 2.47B |
| Bioteque | 2.07B |
| Bionime | 1.91B |
| Chi Sheng Pharma & Biotech | 1.36B |
| ICARES Medicus | 1.09B |